Reverse rate-dependent changes are determined by baseline action potential duration in mammalian and human ventricular preparations László BárándiLászló VirágPéter P. Nánási Original Contribution 03 February 2010 Pages: 315 - 323
Blockage of Angiotensin II type 2 receptor prevents thyroxine-mediated cardiac hypertrophy by blocking Akt activation M. S. Carneiro-RamosG. P. DinizM. L. M. Barreto-Chaves Original Contribution 14 February 2010 Pages: 325 - 335
PDE5A suppression of acute β-adrenergic activation requires modulation of myocyte beta-3 signaling coupled to PKG-mediated troponin I phosphorylation Dong I. LeeSusan VahebiDavid A. Kass Original Contribution 27 January 2010 Pages: 337 - 347
PDGF-CC induces tissue factor expression: role of PDGF receptor α/β Cathérine GebhardAlexander AkhmedovFelix C. Tanner Original Contribution 01 October 2009 Pages: 349 - 356
Low intrinsic aerobic exercise capacity and systemic insulin resistance are not associated with changes in myocardial substrate oxidation or insulin sensitivity Michael SchwarzerSteven L. BrittonTorsten Doenst Original Contribution 05 February 2010 Pages: 357 - 364
Genetic and ultrastructural studies in dilated cardiomyopathy patients: a large deletion in the lamin A/C gene is associated with cardiomyocyte nuclear envelope disruption Pallavi GuptaZofia T. BilinskaFrédérique Tesson Original Contribution 03 February 2010 Pages: 365 - 377
Clopidogrel affects leukocyte dependent platelet aggregation by P2Y12 expressing leukocytes Philipp DiehlChristoph OlivierMartin Moser Original Contribution 27 November 2009 Pages: 379 - 387
Inhibition of the p38 MAP kinase in vivo improves number and functional activity of vasculogenic cells and reduces atherosclerotic disease progression Florian H. SeegerDaniel SeddingStefanie Dimmeler Original Contribution 13 November 2009 Pages: 389 - 397
Peroxisome proliferator-activated receptor-γ activation attenuates cardiac fibrosis in type 2 diabetic rats: the effect of rosiglitazone on myocardial expression of receptor for advanced glycation end products and of connective tissue growth factor Sang-Hyun IhmKiyuk ChangJae-Hyung Kim Original Contribution 23 October 2009 Pages: 399 - 407
Mesenchymal stem cell-based prostacyclin synthase gene therapy for pulmonary hypertension rats Kiyoko TakemiyaHisashi KaiTsutomu Imaizumi Original Contribution 17 October 2009 Pages: 409 - 417
Exposure to cardiomyogenic stimuli fails to transdifferentiate human umbilical cord blood-derived mesenchymal stem cells Santiago RouraJordi FarréAntoni Bayes-Genis Original Contribution 21 January 2010 Pages: 419 - 430
HO-1 gene overexpression enhances the beneficial effects of superparamagnetic iron oxide labeled bone marrow stromal cells transplantation in swine hearts underwent ischemia/reperfusion: an MRI study Yibo JiangLijuan ChenNaifeng Liu Original Contribution 24 December 2009 Pages: 431 - 442